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ABSTRACT 1 
The Salmonella/microsome assay is the most used assay for the evaluation of air particulate 2 
matter (PM) mutagenicity and a positive correlation between strain TA98 responses and 3 
benzo[a]pyrene (B[a]P) levels in PM has been found. However, it seems that the major causes 4 
of PM mutagenicity in this assay are the nitro and oxy-PAHs. Salmonella YG5161, a 30-5 
times more responsive strain to B[a]P has been developed. To verify if YG5161 strain was 6 
sufficiently sensitive to detect mutagenicity associated with B[a]P mutagenicity, PM samples 7 
were collected in Brazil and Sweden, extracted with toluene and tested in the 8 
Salmonella/microsome microsuspension assay. PAHs and B[a]P were determined and the 9 
extracts were tested with YG5161 and its parental strain TA1538. The extracts were also 10 
tested with YG1041 and its parental strain TA98. For sensitivity comparisons, we tested 11 
B[a]P and 1-nitropyrene (1-NP) using the same conditions. The minimal effective dose of 12 
B[a]P was 155 ng/plate for TA1538 and 7 ng/plate for YG5161. Although the maximum 13 
tested dose, 10 m3/plate containing 9 ng of B[a]P in the case of Brazilian sample, was 14 
sufficient to elicit a response in YG5161, mutagenicity was detected at a dose as low as 1 15 
m3/plate (0.9 ng). This is probably caused by nitro-compounds that have been shown to be 16 
even more potent than B[a]P for YG5161. It seems that the mutagenicity of B[a]P present in 17 
PM is not detectable even with the use of YG5161 unless more efficient separation to remove 18 
the nitro-compounds from the PAH extract is performed.19 
 3 
INTRODUCTION 1 
The mutagenicity of airborne particulate matter (PM) can be attributed to at least 500 2 
identified compounds from different chemical classes [Claxton et al., 2004]. Among these, 3 
benzo[a]pyrene (B[a]P), along with other polycyclic aromatic hydrocarbons (PAHs), have 4 
received great attention because of their recognized carcinogenic and mutagenic potential 5 
[Srogi, 2007]. 6 
The Salmonella/microsome assay is the most widely used method for the evaluation of 7 
the mutagenic activity of pure compounds and environmental samples [Claxton et al., 2010], 8 
including atmospheric samples [Claxton and Woodall Jr, 2007]. The assay is sensitive to 9 
several PAHs, including B[a]P [DeMarini et al., 2011; Brito et al., 2013]. Some studies have 10 
correlated the mutagenic activity detected in the Salmonella/microsome assay with the levels 11 
of B[a]P and other non-substituted PAHs present in the samples [Viras et al., 1990; Nielsen et 12 
al., 1996; Claxton and Woodall Jr., 2007; Srogi, 2007], although it does not seem to 13 
demonstrate a direct relationship. The primary components responsible for the mutagenicity 14 
of air particulate matter in the Salmonella assay seem to be nitro and oxy-PAHs [Claxton et 15 
al., 2004; Sharma et al., 2007; Umbuzeiro et al., 2008 a, b; Walgraeve et al., 2010]. One 16 
explanation for this could be that the typically used strains (TA98 and TA100) are more 17 
sensitive to nitro- and oxy- PAHs than to non-substituted PAHs [Claxton et al., 2004; Enya et 18 
al., 1997; Enya et al., 1998; Kummrow et al., 2006; Franco et al., 2010]. To enhance the 19 
sensitivity of the Salmonella/microsome assay to non-substituted PAHs Matsui et al. [2006] 20 
developed the YG5161 strain which is more responsive to B[a]P and other non-substituted 21 
PAHs than its parental strain TA1538. The YG5161 strain overexpresses DNA polymerase 22 
IV, and has the dinB gene of Escherichia coli encoded in the pYG768 plasmid, which also 23 
confers ampicillin resistance to the strain. DNA polymerase IV facilitates the error-prone 24 
bypass of the DNA guanine adducts formed by polycyclic aromatic compounds which, after 25 
 4 
repair, will lead to the deletion of two base pairs and consequently shifting of the reading 1 
frame [Matsui et al., 2006]. These authors suggested the possibility of using YG5161 as a 2 
major strain for the detection of the mutagenicity of non-substituted PAHs such as B[a]P. 3 
Because this compound needs to be metabolized to react with DNA [Uppstad et al., 2010], the 4 
addition of S9 mix is required for its detection in the Salmonella/mutagenicity assay. 5 
Some strains have also been developed to be more sensitive to different compounds. 6 
For example YG1041 strain, a derivative of TA98, is more sensitive to nitroarenes and 7 
aromatic amines because it overproduces nitroreductase and O-acetyltransferases, both 8 
important enzymes in the activation of such compounds [Hagiwara et al., 1993]. Similarly, 9 
the strain YG7108 which is derived from TA1535 is more responsive to alkylating agents 10 
[Yamada et al., 1997]. Both strains have been used in the identification of the types of 11 
compounds predominantly responsible for the mutagenic activity of a test samples 12 
[Umbuzeiro et al., 2011]. Mutlu et al. [2013] demonstrated the applicability of strains with 13 
different sensitivities for analyzing environmental samples. In a hierarchical clustering 14 
analysis they showed that although PAHs, aromatic amines, and nitro-compounds were 15 
present in diesel exhaust extracts, oxy-PAHs were the cause of much of the mutagenicity. 16 
When atmospheric particulate air samples are tested they usually demonstrate a clear 17 
increase with YG1041 in relation to TA98, indicating that the mutagenicity is related to nitro- 18 
and oxy- PAHs and not B[a]P, although PAHs are present in those samples when chemical 19 
analyses are performed [DeMarini et al., 2004; Umbuzeiro et al., 2008a,b]. 20 
 The objective of this work was to verify if the YG5161 strain in the 21 
Salmonella/microsome microsuspension assay was sufficiently sensitive to B[a]P 22 
mutagenicity in air particulate matter collected in two different locations, Limeira, Brazil and 23 
Stockholm, Sweden. We determined the total PAH and B[a]P levels and tested the same 24 
extracts with YG5161 and its parental strain, TA1538. We also tested the same extracts with 25 
 5 
YG1041 and its parental strain, TA98. For sensitivity comparisons we tested several 1 
concentrations of B[a]P and 1-nitropyrene (1-NP) using the same conditions. 2 
 3 
MATERIAL AND METHODS 4 
 Sampling sites 5 
 Total atmospheric particulate matter (PM) was collected at two sites: the campus of 6 
the Faculty Technology at UNICAMP, Limeira, Brazil (LIMEIRA) and the campus of the 7 
Stockholm University, Stockholm, Sweden (STHOLM). The LIMEIRA site is impacted by 8 
heavy traffic including cars and trucks, industrial emissions, and sugar cane growing and 9 
harvesting activities, including biomass burning. The mutagenic potencies of previously 10 
evaluated extracts from this site using the Salmonella/microsome assay [Alves, 2011] and 11 
surrounding areas [Umbuzeiro et al., 2008a, b] were among the highest potencies found in the 12 
literature.  The STHOLM site is also impacted by heavy traffic with emissions from cars and 13 
trucks as the main source of pollution. PM samples from this site have recently been used to 14 
investigate the toxicological impact of PAHs in air PM [Jarvis et al., 2013a,b]. 15 
Total PM samples from Limeira were collected at street level on a glass-fiber filter 16 
(254 × 233 mm; 0.33 mm pore size. Energética Ind. Com. LTDA, Rio de Janeiro, RJ, Brazil) 17 
using a high-volume sampler (Energética Ind. Com. LTDA, Rio de Janeiro, RJ, Brazil) 18 
operated at an average flow rate of 1,130 L/min
 
for 24 h. The air total PM samples from 19 
Stockholm, Sweden were collected at roof-top level (22 m from the ground) on a 20 
fluorocarbon-coated glass fiber filter (235 mm of diameter; Fiberfilm Filters, Pallflex, Pall 21 
Corporation, Putnam, CT, USA) with an average flow rate of 1,209 L/min for 71 h. The total 22 
PM concentrations for Limeira were 95.8 ug/m
3
 and for Stockholm, 7.16 ug/m
3
. 23 
 24 
Organic extraction and PAH analysis 25 
 6 
Extraction was performed by pressurized fluid extraction using an ASE 200 1 
accelerated solvent extraction system (Dionex Co., Sunnyvale, CA, USA) using toluene for 5 2 
x 30 min. This extraction procedure was previously developed and validated for analysis of 3 
PAHs in air PM [Bergvall and Westerholm, 2008].  Aliquots of the extracts were evaporated 4 
gently under a nitrogen stream at 55°C until dryness and re-dissolved in dimethylsulfoxide 5 
(DMSO) for the biological assays. Portions of the extracts were analyzed for 42 PAHs (Table 6 
I) using silica solid phase extraction (SPE) cartridges and on-line liquid chromatography-gas 7 
chromatography/mass spectrometry as described in detail elsewhere [Sadiktsis et al., 2014]. A 8 
blank filter was also extracted and analyzed as an analytical control.  9 
 10 
Salmonella/microsome microsuspension assay 11 
The extracts were assayed in the Salmonella/microsome microsuspension assay [Kado 12 
et al., 1983; DeMarini et al., 1989] in dose-response experiments using the Salmonella strains 13 
TA1538, TA98, YG5161 and YG1041 with and without metabolic activation (S9). Strains 14 
were kindly provided by Dr. Takehiko Nohmi, except for TA98, which was kindly provided 15 
by Dr. Larry Claxton. Table II summarizes the genetic characteristics of the strains. B[a]P and 16 
1-NP were also tested with the four strains in dose response experiments. Overnight cultures 17 
(around 10
9
 cells/mL) were concentrated 5-fold by centrifugation (10,000xg at 4 
o
C for 10 18 
min) and resuspended into 0.015 M sodium phosphate buffer. A volume of 50 µL of cell 19 
suspension, 50 µL of 0.015 M sodium phosphate buffer or S9 mix, and 5 µL of the sample 20 
were incubated at 37 
o
C for 90 min without shaking. To the mixture, 2 mL of molten agar was 21 
added and poured onto a minimal agar plate. Colonies were counted after 66 h of incubation 22 
at 37 
o
C by hand with the aid of a stereomicroscope. Toxicity was also carefully evaluated by 23 
observing the background of the agar plates. Metabolic activation was provided by Aroclor 24 
 7 
1254-induced Sprague Dawley rat liver S9 mix (MolTox, Boone, NC) prepared at 4 % v/v 1 
and supplemented with the required co-factors [Mortelmans and Zeiger, 2000].  2 
PM extracts were tested at 0.02, 0.2, 1, 2, 5 and 10 m³ per plate. Positive controls 3 
without S9 were 4-nitroquinoline-oxide (4NQO) at 0.125 µg/plate for TA98 and YG5161 and 4 
4-nitro-o-phenylenediamine (4NOP) at 2.5 µg/plate for YG1041. With S9, 2-aminoanthracene 5 
(2AA) at 0.625 µg/plate was used as a positive control for TA1538, TA98 and YG5161 and at 6 
0.03125 µg/plate for YG1041. Duplicates of each concentration were tested, except for the 7 
negative control that was tested in triplicate. DMSO was used as negative control and to 8 
dilute the extracts and positive controls. The extract of a clean (blank) filter was also tested.  9 
Data were analyzed with the Salanal computer program using the Bernstein model 10 
[Bernstein et al., 1982]. Samples were considered positive when a significant difference 11 
among the tested doses and the negative control (ANOVA) and a significant positive dose 12 
response were observed. Results were expressed as revertants per m
3
 and per mg of PM 13 
equivalent. Also, the minimum effective dose (MED) to elicit a positive response was 14 
calculated for B[a]P and 1-NP.  MED was defined as the dose that provided a doubling of 15 
revertants based on the calculated linear regression curve.  16 
 17 
RESULTS AND DISCUSSION 18 
 19 
 In this study, we evaluated the mutagenicity of PM organic extracts from two cities: 20 
Limera, Brazil and Stockholm, Sweden. The concentration of PM collected in LIMEIRA 21 
was 95.8 µg/m
3
 and in STHOLM was 7.16 µg/m
3
. The total PAH content in the LIMEIRA 22 
sample was 10.66 ng/m
3 
with 0.9 ng/m
3
 of B[a]P, and the STHOLM sample contained 4.43 23 
ng/m
3 
with 0.29 ng/m
3
 of B[a]P (Table I). The mean of the number of revertants per plate 24 
obtained for the four strains including negative, blank, positive controls and calculated 25 
potencies are presented in Table III for LIMEIRA and Table IV for STHOLM. In LIMEIRA, 26 
 8 
the potency for TA98 without S9 was 100 revertants/m
3
, similar what had been reported for 1 
other cities in Brazil [Sato et al., 1995; Ducatti and Vargas, 2003; Umbuzeiro et al., 2008 a, 2 
b]. The potency of the STHOLM sample was 4 times lower (25 revertants/m
3
). The potency 3 
values decreased for both locations when S9 was used (Tables III and IV). According to 4 
Claxton et al. [2004] this is a first indication of a response of nitroaromatics. In general the 5 
samples from LIMEIRA were more mutagenic than the STHOLM in all strains/conditions 6 
tested, especially with TA98 with S9 (13-fold difference). However, because only one sample 7 
from each site was analyzed it was not possible to compare the mutagenicity of the two sites 8 
with a high level of confidence. A comprehensive study, which includes additional sampling 9 
at the same season of the year, is being conducted to provide additional information on the 10 
potencies at both sites. 11 
To establish how sensitive each strain was to B[a]P, the prototypical non-substituted 12 
PAH, and 1-NP, a typical nitroaromatic, their mutagenicities were assessed using the same 13 
protocol used to evaluate the PM samples. 14 
 YG5161 was the most sensitive strain for B[a]P showing a MED of 7 ng/plate in 15 
contrast to 77.5 ng/plate for TA1538, 265 ng/plate for YG1041, and 1,400 ng/plate for TA98 16 
(Table V). Although several non-substituted PAHs were detected in both PM samples (Table 17 
II), the potency of the YG5161 response did not provide a typical B[a]P response, which 18 
would be an increase of 30-fold in relation to TA1538 (Table V). This is most likely due to 19 
the fact that the amount of B[a]P present in the 10 m
3
 of PM (the maximum dose tested) was 20 
9 ng/plate and the MED of B[a]P for YG5161 is 7 ng/plate (Table V). All the comparisons 21 
were made with S9 because non-substituted PAHs require S9 to be activated.  22 
YG1041, as expected, demonstrated much higher sensitivity to 1-NP than any other 23 
strain, with a MED of 0.03 ng/plate. MEDs for TA98, TA1538 and YG5161 were 0.45, 1.8 24 
and 1.8 ng/plate, respectively (Table VI). 1-NP was chosen as an example for testing purpose, 25 
 9 
but other nitrocompounds (e.g. dinitropyrenes, nitrobenzanthrones) are more mutagenic and 1 
are likely to be present in PM samples.  For both PM samples we observed a typical response 2 
of nitroaromatics because the potency of YG1041 was 35 times higher than TA98. This 3 
comparison was made without S9 because all the potencies decreased with S9. This behavior 4 
is consistent with the hypothesis that nitroaromatics are the major cause of the mutagenic 5 
effect. 6 
The data suggest that B[a]P is not the compound predominantly causing the mutagenic 7 
responses of the PM analyzed in this study, but that nitroaromatics such as 1-NP seems to be 8 
causing the observed effect. Chemical analysis of nitroaromatics could be performed in the 9 
same extracts in order to determine their contribution to the mutagenicity.  10 
Other authors also used YG5161 to test different samples. Sharma et al. [2007] used 11 
TA98, YG1041, and YG5161 strains, in the Salmonella/microsome microsuspension assay to 12 
evaluate the genotoxicity of organic fractions of PM collected from an incineration energy 13 
plant and urban air. The fraction containing moderately polar PAHs, alkyl-PAHs and O- and 14 
S-heterocyclics was mutagenic only in the presence of S9 mix, indicating that compounds 15 
such as B[a]P could be responsible for the observed effect. Because the mutagenic activity 16 
with the YG5161 strain was lower in comparison to TA98 it is plausible to suspect that non-17 
substituted PAHs are not predominantly contributing to the observed mutagenic activity. 18 
Conversely, the fraction containing N-heterocyclics, nitro-, amino- and oxy-PAHs was more 19 
mutagenic without S9 and higher in YG1041 than TA98, suggesting that nitroarenes and 20 
aromatic amines are likely to be the major cause of the mutagenic activity. 21 
Maertens et al. [2009] used the Salmonella/microsome assay with several 22 
strains/conditions, including TA98, YG1041 and YG5161 to, evaluate the mutagenicity of 23 
tobacco and marijuana smoke condensates. All of the tested smoke condensates presented 24 
positive responses. The mutagenic potencies obtained with YG1041 and with YG5161 were 25 
 10 
higher than the ones with TA98 indicating that aromatic amines and non-substituted PAHs 1 
were contributing to the mutagenicity. Although the authors identified B[a]P and 2 
benzo[a]anthracene in the samples, they contributed to less than 0.1% of the total 3 
mutagenicity indicating that there are other major mutagens in the mixture. 4 
Yauk et al. [2012] observed mutagenic activity in cigarette smoke condensate extracts 5 
using the Salmonella/microsome assay with the TA98, YG1041, and YG5161 strains in the 6 
presence of S9 mix. The authors observed that the potencies with YG1041 were greater than 7 
those for TA98 but the increase of YG5161 potencies in relation to TA98 was not significant, 8 
indicating that non-substituted PAHs could not fully explain the mutagenicity. 9 
Therefore we conclude that even the highly sensitive strain to B[a]P, YG5161, does 10 
not seem to be able to distinguish the response of B[a]P in samples containing nitroaromatics. 11 
We observe that only 1 m
3
 is sufficient to elicit a positive response in the 12 
Salmonella/microsuspension assay for the majority of the strains/conditions. Both for the 13 
LIMEIRA and STHOLM air samples.   14 
Therefore we can suggest that although associations were observed between B[a]P 15 
content and mutagenicity, this compound does not totally explain  the mutagenicity of PM air 16 
samples tested in the Salmonella/microsome assay unless amounts of B[a]P are higher than 7 17 
ng/plate and nitrocompounds are eliminated by the fractionation procedure. 18 
 19 
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TABLE I. PAHs content (pg/m
3
) in extracts of the PM samples collected in Limeira, 
Brazil and Stockholm, Sweden. 
 LIMEIRA STHOLM 
PAH (pg/m
3
) (pg/m
3
) 
 
Mean  SD Mean  SD 
Phenanthrene 798 27 250 2 
Anthracene 180 14 33.6 0.7 
3-Methylphenanthrene 47.0 2.5 23.8 0.7 
2-Methylphenanthrene 65.4 2.1 32.0 1.3 
2-Methylanthracene 14.8 0.7 5.75 0.52 
9-Methylphenanthrene 34.5 1.5 18.0 1.4 
1-Methylphenanthrene 43.3 4.2 37.2 0.8 
4H-Cyclopenta[def]phenanthrene 58.9 2.0 47.8 0.1 
2-Phenylnaphthalene 35.0 2.9 26.9 2.6 
3,6-Dimethylphenanthrene 5.03 0.20 1.70 0.11 
3,9-Dimethylphenanthrene 22.9 1.5 8.31 0.75 
Fluoranthene 671 6 368 6 
Pyrene 895 25 439 8 
1-Methylfluoranthene 40.9 3.5 46.1 3.7 
Benzo[a]fluorene 28.7 1.2 27.0 2.4 
Benzo[b]fluorene 16.2 1.5 13.0 0.8 
2-Methylpyrene 30.8 2.9 18.4 1.4 
4-Methylpyrene 52.3 4.7 30.7 2.9 
1-Methylpyrene 47.7 3.9 32.1 3.2 
Benzo[ghi]fluoranthene 346 15 207 8 
Benzo[c]phenanthrene 48.5 3.4 77.6 2.1 
Benzo[b]naphto(1,2-d)thiophene 9.95 0.31 2.16 0.71 
Benz[a]anthracene 332 3 306 10 
3-Methylchrysene 39.1 2.3 21.2 2.0 
2-Methylchrysene 61.0 3.3 47.9 3.5 
6-Methylchrysene 40.2 2.5 32.6 2.5 
1-Methylchrysene 47.1 2.6 51.5 3.3 
Benzo[b]fluoranthene 974 19 465 8 
Benzo[k]fluoranthene 440 5 180 4 
Benzo[e]pyrene 1050 31 352 13 
Benzo[a]pyrene 899 17 289 4 
Perylene 164 6 45.1 0.2 
Indeno[1,2,3-cd]fluoranthene 65.4 1.5 28.2 0.3 
Indeno[1,2,3-cd]pyrene 908 28 230 12 
Dibenz[a,h]anthracene 55.9 2.7 35.6 3.3 
Picene 76.2 2.2 30.9 1.7 
Benzo[ghi]perylene 1620 35 351 7 
Dibenzo[a,l]pyrene 4.79 0.37 5.14 0.28 
Dibenzo[a,e]pyrene 15.7 0.6 32.4 2.0 
Coronene 366 8 171 10 
Dibenzo[a,i]pyrene 9.23 0.28 3.66 0.17 
Dibenzo[a,h]pyrene 3.03 0.11 2.53 0.19 
Total 10,663  4,427  
 
  
TABLE II. Summary of the main genetic characteristics of Salmonella typhimurium 
specific strains.  
Strain Description Reversion event Plasmids Reference 
TA1538 hisD3052, ∆(uvrB, bio), rfa Frameshift No plasmids Maron and Ames, 
[1983] 
TA98 hisD3052, ∆(uvrB, bio), rfa, 
Apr 
Frameshift pKM101 Maron and Ames, 
[1983] 
YG1041 hisD3052,  ∆ (uvrB, bio), rfa, 
Apr and Kmr, NR and O-AT 
overproducing strain 
 
Frameshift pKM101, 
pYG233 
 
Hagiwara et al. 
[1993] 
YG5161 hisD3052, ∆(uvrB, bio), rfa, 
Apr, DNA Pol IV 
overproducing 
 
Frameshift pYG768 Matsui et al. [2006] 
 
his – mutation in the histidine operon 
∆uvrB – deletion of uvrB gene 
∆bio – deletion of biotin gene 
rfa – mutation cause partial loss of the lipopolysaccharide barrier 
Apr – resistant to ampicillin 
NR – nitroreductase 
O-AT – O-acetyltransferase 
DNA Pol. IV – DNA Polymerase IV 
Kmr – resistant to Kanamycin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE III. Mutagenicity for LIMEIRA PM extracts in the Salmonella/microsome 
microsuspension assay with TA98, YG1041, TA1538 and YG5161 without and with S9. 
Doses  Mean of Number of Revertants/plate and  Standard Deviation (SD) 
 
m
3
/plate 
 TA98  YG1041 
 -S9 +S9  -S9 +S9 
 Mean SD Mean SD  Mean SD Mean SD 
Negative control  52.7 4.51 53.3 14.4  157.7 17.1 145.7 9.1 
0.02  53.5 2.12 58.0 7.1  262.0 24.1 151.5 17.7 
0.2  68.5 6.4 59.5 0.7  849.5 7.8 329.5 16.3 
1  144.0* 22.6 69.0 8.5  1,922.5 160.5 1,344.0 73.5 
2  207.5 45.9 59.0 2.8  3,583.5 231.2 3,312.5 50.2 
5  595.5 37.5 76.0 9.9  4,145.5 381.1 5,308.0 151.3 
10  1,110.0 70.7 133.0 18.4  3,861.5 362.7 6,355.5 0.7 
Blank Filter  60.0 1.4 47.0 2.8  146.0 30.4 137.0 11.3 
Positive control  927.0 101.1 1,518.0 352.8  908.0 173.9 2,344.0 7 
Potency 
revertants/m
3
 
 
100 6.3  3,500 1,100 
Doses  Mean of Number of Revertants/plate and Standard Deviation (SD) 
 
m
3
/plate 
 TA1538  YG5161 
 -S9 +S9  -S9 +S9 
 Mean SD Mean SD  Mean SD Mean SD 
Negative control  15.0 2.0 12.7 2.5  26.3 4.0 28.0 2.65 
0.02  16.5 0.7 14.5 2.1  23.5 0.7 29.5 7.8 
0.2  28.0 2.8 18.5 2.1  43.0 7.1 34.0 7.1 
1  89.5 0.7 52.0 9.9  99.0 2.8 57.5 2.1 
2  146.0 18.3 69.0 14.1  136.0 4.2 85.5 3.5 
5  306.5 24.7 147.5 13.4  272.0 4.2 162.0 7.1 
10  429.0 38.2 209.0 1.4  395.0 8.5 179.0 28.3 
Blank Filter  20.0 1.4 21.0 9.2  18.0 0.7 29.0 6.4 
Positive control  392.0 50.2 2,451.0 746.0  677.0 111.0 3,114.0 514.1 
Potency 
revertants/m
3
 
 
62 28  61 27 
*Shaded values represent the number of revertants that equal or more than twice the negative 
controls 
 
 
 
 
 
 
TABLE IV. Mutagenicity data for STHOLM PM extracts of the Salmonella/microsome 
microsuspension assay with TA98, YG1041, TA1538 and YG5161 without and with S9.  
Doses  Mean of Number of Revertants/plate and Standard Deviation (SD) 
 
m
3
/plate 
 TA98  YG1041 
 -S9 +S9  -S9 +S9 
 Mean SD Mean SD  Mean SD Mean SD 
Negative control  52.7 4.5 53.3 14.4  157.7 17.1 145.7 9.1 
0.02  58.5 6.4 51.5 3.5  173.5 6.4 157.0 5.7 
0.2  61.0 12.7 43.0 1.4  364.5 2.1 173.5 16.3 
1  73.0 1.4 50.0 5.7  936.0 135.7 418.5 4.9 
2  93.0 14.1 58.0 8.5  2,108.0 159.8 683.5 37.5 
5  195.0* 59.4 70.5 3.5  3,790.0 181.0 1,059.5 33.2 
10  728.0 31.1 98.5 0.7  4,695.0 29.7 2,885.5 191.6 
Blank filter  50.0 11.3 57.0 14.8  178.0 24.0 153.0 3.5 
Positive control  927.0 101.1 1,518.0 352.8  908.0 173.9 2,344.0 171.1 
Potency 
revertants/m
3
 
 
25 4.8  890 270 
Doses  Mean of Number of Revertants/plate and Standard Deviation (SD) 
 
m
3
/plate 
 TA1538  YG5161 
 -S9 +S9  -S9 +S9 
 Mean SD Mean SD  Mean SD Mean SD 
Negative control  15.0 2.0 12.7 2.5  26.3 4.0 28.0 2.6 
0.02  15.0 1.4 11.5 3.5  26.5 2.1 20.0 0.0 
0.2  24.0 2.8 20.5 3.5  27.5 9.2 28.5 2.1 
1  38.0 0.0 30.0 4.2  40.0 0.0 36.0 2.8 
2  66.0 8.5 47.0 1.4  55.5 0.7 58.0 2.8 
5  162.5 9.2 93.5 19.1  129.0 5.6 101.5 16.3 
10  264.5 41.7 117.0 1.4  213.5 9.2 143.0 5.7 
Blank filter  14.0 4.2 18.0 7.1  26.0 2.8 25.0 7.8 
Positive control  392.0 50.2 2,451.0 746.0  677.0 111.0 3,114.0 514.1 
Potency 
revertants/m
3
 
 
26 12  18 15 
*Shaded values represent the number of revertants that equal or more than twice the negative 
controls 
 
 
 
 
 
 
 
 
 
 
 
TABLE V. Mutagenic responses in the Salmonella/microsome microsuspension assay for 
benzo[a]pyrene with the strains, TA98, YG1041, TA1538 and YG5161 in the presence of 
S9. 
Doses Mean of Number of Revertants/plate and Standard Deviation (SD) 
ng/plate 
TA98 YG1041 TA1538 YG5161 
Mean SD Mean SD Mean SD Mean SD 
Negative 
control 28.0 7.1 159.0 21.2 15.5 0.7 21.0 5.7 
0.5       32.0 7.1 
1.0       28.5 0.7 
2.0       34.0 2.8 
4.0       48.5 3.5 
7.8 32.5 3.5 164.5 29.0 14.5 0.7 47.5 2.1 
15.6 31.0 1.7 183.0 35.4 25.0 5.7 71.5 6.4 
31.2 37.5 3.5 210.5 10.6 30.5 4.9 114.0 1.4 
62.5 30.5 7.8 214.0 21.2 44.0 17.0 110.5 12.0 
125 37.5 9.2 306.0 31.1 49.5 12.0 155.0 8.5 
250 42.5 6.4 339.0 38.2 68.0 4.2 203.5 19.1 
500 39.0 5.7 462.5 17.7 98.5 10.6 230.0 5.7 
1,000 60.0* 14.1 471.0 9.9 125.5 27.6 285.0 1.4 
2,000 63.0 11.3 470.5 0.7 106.0 5.7 271.5 2.1 
Potency 
revertants/ng 
0.02 0.6 0.2 3.0 
 
MED** 
 
1,400 
 
265 
 
77.5 
 
7 
*Shaded values represent the number of revertants that equal or more than twice the negative 
controls 
**MED = Minimal Effective Dose in ng/plate  
 
 
 
 
 
 
 
 
 
TABELA VI. Mutagenic responses in the Salmonella/microsome microsuspension assay 
for 1-nitropyrene with the strains, TA98, YG1041, TA1538 and YG5161 in the absence 
of S9. 
 
Doses Mean of Number of Revertants/plate and Standard Deviation (SD) 
ng/plate 
TA98 YG1041 TA1538 YG5161 
Mean SD Mean   SD Mean SD Mean SD 
Negative 
control 42.5 4.9 201.0 21.2 18.0 0 24.0 4.2 
0.01   257.5 10.6     
0.02   310.5 23.3     
0.03   383.0 35.4     
0.04   410.5 2.1     
0.05   506.5 24.7     
0.1 48.0 2.8 791.5 3.5 18.5 0.7 33.5 10.6 
0.3 58.0 15.6 3,063.5 101.1 17.5 7.8 29.0 5.7 
0.7 101.0* 7.1 4,353.0 110.3 28.5 6.4 45.5 0.7 
1.0 129.5 0.7   19.0 5.7 36.0 5.7 
2.5 266.0 41.0   36.5 3.5 68.0 11.3 
5.0 536.5 140.7   63.5 0.7 76.5 13.4 
10 1,001.0 75.0   139.5 46.0 135.0 33.9 
20 1,883.5 82.7   595.0 110.3 334.0 19.8 
Potency 
revertants/ng 
94 5,900 10 13 
 
MED** 
 
0.45 
 
0.03 
 
1.8 
 
1.8 
*Shaded values represent the number of revertants that equal or more than twice the negative 
controls 
**MED - Minimal Effective Dose in ng/plate 
 
